5-(4-(2-(n-methyl-n-(2-pyridyl)amino)eth oxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical

Details for Australian Patent Application No. 2001262550 (hide)

Owner SmithKline Beecham p.l.c.

Inventors Millan, Michael John; Ho, Tim Chien Ting; Craig, Andrew Simon

Agent Davies Collison Cave

Pub. Number AU-B-2001262550

PCT Pub. Number WO01/94343

Priority 0014005.3 08.06.00 GB

Filing date 8 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 22 April 2004

International Classifications

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 003/10 Drugs for disorders of the metabolism

A61K 031/4439

A61K 031/425 - Thiazoles

Event Publications

22 April 2004 Application Accepted

  Published as AU-B-2001262550

12 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001262551-Assembly and method for use in terminating an optical fibre or fibres

2001262549